Example collocations logo

Vaccines in sentence

693 examples of Vaccines in a sentence

The World Health Organization has warned that the Sustainable Development Goal of eradicating TB by 2035 will not be achieved unless new drugs, better diagnostics, and improved vaccines are developed.
Even vaccines that are already available are not being used widely enough to have a large impact on antibiotic use and resistance.
Vaccines also have an important role to play in protecting livestock and fish from infections, optimizing the application of antibiotics in agriculture – where their overuse is an important cause of growing resistance.
Maximizing the potential of vaccines to fight antimicrobial resistance thus requires the wider application of existing vaccines in humans and animals.
But it also entails developing new vaccines, which, in the short-term, could be kick-started by a $2 billion Global Innovation Fund for early-stage research in vaccines and other viable alternatives to antibiotics.
So can the proactive use of oral cholera vaccines and quick access to treatments, such as oral rehydration solution and intravenous fluids.
For this reason, the roadmap also encourages the preemptive and large-scale deployment of oral vaccines in cholera hotspots.
The vaccines work immediately, and can prevent cholera for up to three years, serving as a bridge to the implementation of longer-term solutions.
Oral cholera vaccines are available via a global stockpile maintained by the World Health Organization, with support from Gavi, the Vaccine Alliance.
It has enabled the development of vaccines against infectious diseases and drugs that treat non-infectious illnesses like diabetes, cancer, cystic fibrosis, psoriasis, rheumatoid arthritis, and some genetic disorders.
Perhaps the biggest contribution that the Gates Foundation made to that decline was pledging $750 million to establish the Global Alliance for Vaccines and Immunization (now known as Gavi, the Vaccine Alliance), a public-private initiative that works with governments and United Nations agencies to improve the rate of vaccination in poor countries and foster the development of new vaccines.
Now 86% of the world’s children receive basic vaccines – the highest rate ever.
There are many possible interventions – such as providing folic acid to prevent birth defects, introducing new vaccines, or treating infections earlier – that we know could have an impact on child mortality.
The revenues collected – easily hundreds of billions of dollars annually – could be spent on global public goods such as development assistance, vaccines for tropical diseases, and the greening of technologies in use in the developing world.
Look for new global cooperative approaches to clean energy systems, medicines and vaccines, improved techniques for fish farming, drought-and-temperature resistant crop varieties, high-mileage automobiles, and low-cost irrigation techniques.
Just as they confronted problems in the past, our scientists and entrepreneurs have brought us solutions by way of the Green Revolution, new vaccines, communications technology, and cleaner energy.
Taking advantage of it will require the rapid development and dissemination of effective diagnostic tools, novel drug treatments, and innovative vaccines, in conjunction with efforts to ensure that health-care systems are equipped to deliver the right care.
They include low-cost drugs to reduce heart attacks, vaccines to prevent cervical cancer, and the same tobacco taxes and advertising rules that dramatically cut smoking rates throughout Europe and the US.
It is noteworthy that China’s chaotic effort to vaccinate 14 billion chickens has been compromised by counterfeit vaccines and the absence of protective gear for vaccination teams, which might actually spread disease by carrying fecal material on their shoes from one farm to another.
They would obtain timely warning of the existence of an H5N1 strain that is transmissible from human to human, but would focus the vast majority of their funding on parallel, low- and high-tech approaches – vaccines, drugs, and other public health measures – that would primarily benefit themselves.
A flu pandemic will require triage on many levels, including not only decisions about which patients are likely to benefit from scarce commodities such as drugs, vaccines, and ventilators, but also broader public policy choices about how best – among, literally, a world of possibilities – to expend resources.
If the concept of “viral sovereignty” had been applied to HIV 25 years ago, we would not have central repositories of thousands of varieties of HIV today; these allow scientists to test drugs and vaccines against all the different strains of the virus that causes AIDS.
Without access to the viruses, it is impossible to verify the accuracy of such genetic information or to develop vaccines against the deadly microbes.
Outrageously, Supari has charged that the WHO would give any viruses – not just H5N1 – to drug companies, which in turn would make products designed to sicken poor people, in order “to prolong their profitable business by selling new vaccines” (a charge oddly reminiscent of the plot of John le Carré’s novel The Constant Gardener ).
Given the lack of effective vaccines and inexpensive, easily deliverable drugs, reducing tsetse numbers is the most effective approach to controlling such diseases.
Supplying vaccines, for example, requires infrastructure, logistical coordination, and trained personnel.
Unfortunately, action has been lacking in the development of new diagnostics, vaccines (and vaccine alternatives), and antibiotics.
We also recommended that those developing new vaccines or alternatives and state-of-the-art diagnostics be eligible for such rewards, given that these innovations can vastly reduce the misuse of antimicrobials.
The $20 billion prize could be divided among the companies that first produce appropriate new diagnostic technologies, vaccines, or antibiotics to address the World Health Organization’s 12 “priority pathogens.”
Doing so in the early 2000s to finance vaccines saved millions of lives in the developing world.
BackNext